Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Memantine in Major Depressive Disorder
NCT07139834Phase 1Recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing SSRI + Memantine with SSRI + Placebo (2 arms). Primary endpoint: Pattern Separation Performance at week 11. Started Jun 2026; status: recruiting.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07139834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07139834.